$11.4B
$320,000
0.0% of portfolio
8,936
Q1 2025
Added 2.13%
$2.47B
$135,000
0.0% of portfolio
2,148
Q1 2025
Added 1.85%
$1.32B
$86,000
0.0% of portfolio
5,254
Q1 2025
Added 3.1%
$2.53B
$171,000
0.0% of portfolio
7,525
Q1 2025
Added 15.61%
$2.22B
$104,000
0.0% of portfolio
1,244
Q4 2024
Added 50.79%
$3.75B
$172,000
0.0% of portfolio
2,249
Q1 2025
Reduced 79.98%
$3.52B
$161,000
0.0% of portfolio
3,523
Q1 2025
Reduced 10.26%
$1.95B
$122,000
0.0% of portfolio
4,035
Q4 2024
Added 50.11%
$3.71B
$85,000
0.0% of portfolio
5,093
Q4 2024
Added 67.04%
$1.83B
$99,000
0.0% of portfolio
4,733
Q4 2024
Added 44.08%
$5.11B
$246,000
0.0% of portfolio
4,496
Q4 2024
Added 40.32%
$5.08B
$44,000
0.0% of portfolio
635
Q1 2025
New
$1.5B
$62,000
0.0% of portfolio
8,378
Q4 2024
New
$1.85B
$90,000
0.0% of portfolio
910
Q1 2025
Added 11.79%
$1.34B
$92,000
0.0% of portfolio
6,968
Q4 2024
Added 74.59%
$5.65B
$166,000
0.0% of portfolio
1,654
Q4 2024
Added 31.9%
$2.92B
$106,000
0.0% of portfolio
2,707
Q1 2025
Added 2.11%
$4.82B
$164,000
0.0% of portfolio
1,718
Q4 2024
Added 56.75%
-
$205,000
0.0% of portfolio
-
Q3 2024
New
$4.75B
$147,000
0.0% of portfolio
1,231
Q4 2024
Added 63.26%
$7.05B
$213,000
0.0% of portfolio
1,269
Q1 2025
Added 2.01%
$14.2B
$476,000
0.0% of portfolio
10,525
Q1 2025
Added 8.53%
$2.72B
$84,000
0.0% of portfolio
1,162
Q1 2025
Added 3.11%
$1.95B
$77,000
0.0% of portfolio
2,615
Q4 2024
Added 30.49%
$6.01B
$334,000
0.0% of portfolio
4,332
Q1 2025
Reduced 90.06%
$896M
$70,000
0.0% of portfolio
16,198
Q1 2025
New
$6.25B
$226,000
0.0% of portfolio
4,681
Q4 2024
Added 39.94%
-
$299,000
0.0% of portfolio
-
Q4 2022
Added 50.0%
-
$293,000
0.0% of portfolio
-
Q3 2023
Reduced 25.0%
-
$286,000
0.0% of portfolio
-
Q3 2024
New
$2.51B
$120,000
0.0% of portfolio
2,971
Q1 2025
New
$2.57B
$93,000
0.0% of portfolio
520
Q4 2024
Added 57.1%
$2.8B
$118,000
0.0% of portfolio
2,128
Q1 2025
Added 10.83%
$5.94B
$76,000
0.0% of portfolio
1,551
Q1 2025
New
$2.09B
$103,000
0.0% of portfolio
1,495
Q4 2024
Added 41.3%
$6.64B
$693,000
0.0% of portfolio
9,622
Q1 2025
Reduced 59.47%
$11.6B
$515,000
0.0% of portfolio
23,418
Q1 2025
Added 37.85%
$5.1B
$330,000
0.0% of portfolio
10,812
Q1 2025
Reduced 2.9%
$1.31B
$66,000
0.0% of portfolio
3,835
Q3 2024
Added 53.58%
$2.43B
$140,000
0.0% of portfolio
23,543
Q1 2025
Added 3.25%
$2.58B
$73,000
0.0% of portfolio
2,766
Q1 2025
New
$10.7B
$301,000
0.0% of portfolio
5,779
Q1 2025
Added 14.23%
$5.94B
$154,000
0.0% of portfolio
6,127
Q1 2025
Reduced 72.57%
$3.65B
$119,000
0.0% of portfolio
1,808
Q1 2025
Reduced 25.63%
$2.59B
$107,000
0.0% of portfolio
2,136
Q1 2025
Added 1.57%
$15.2B
$1.06 Million
0.0% of portfolio
16,462
Q1 2025
Reduced 24.82%
$8.88B
$344,000
0.0% of portfolio
3,596
Q1 2025
Added 3.66%
Alnylam Pharmaceuticals Inc
-
$346,000
0.0% of portfolio
-
Q4 2023
New
$1.85B
$59,000
0.0% of portfolio
473
Q4 2024
Added 58.72%
$0
$36,000
0.0% of portfolio
1,654
Q1 2025
New